PERIWOUND Trademark

Trademark Overview

On Friday, September 8, 2023, a trademark application was filed for PERIWOUND with the United States Patent and Trademark Office. The USPTO has given the PERIWOUND trademark a serial number of 98171131. The federal status of this trademark filing is RESPONSE AFTER FINAL REJECTION - ENTERED as of Thursday, March 6, 2025. This trademark is owned by The Bioregentech Institute, Inc.. The PERIWOUND trademark is filed in the Medical Instrument Products category with the following description:

Electronic nerve stimulators for medical purposes; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulation electrodes; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulation instruments; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulators
periwound

General Information

Serial Number98171131
Word MarkPERIWOUND
Filing DateFriday, September 8, 2023
Status663 - RESPONSE AFTER FINAL REJECTION - ENTERED
Status DateThursday, March 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkPERI WOUND
Goods and ServicesElectronic nerve stimulators for medical purposes; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulation electrodes; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulation instruments; Electronic nerve stimulators for medical purposes, namely, transcutaneous electrical nerve stimulators

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, October 1, 2023
Primary Code010
First Use Anywhere DateWednesday, March 5, 2025
First Use In Commerce DateWednesday, March 5, 2025

Trademark Owner History

Party NameThe Bioregentech Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Tuesday, September 12, 2023NEW APPLICATION ENTERED
Sunday, October 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Wednesday, February 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024NON-FINAL ACTION WRITTEN
Thursday, February 8, 2024NON-FINAL ACTION E-MAILED
Thursday, February 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 24, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, May 24, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 24, 2024PETITION TO REVIVE-GRANTED
Wednesday, July 24, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 24, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, July 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024ASSIGNED TO LIE
Wednesday, December 11, 2024FINAL REFUSAL WRITTEN
Wednesday, December 11, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 11, 2024FINAL REFUSAL E-MAILED
Wednesday, March 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 5, 2025TEAS AMENDMENT OF USE RECEIVED
Wednesday, March 5, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, March 5, 2025AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, March 5, 2025USE AMENDMENT FILED
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 6, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 6, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 6, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

periwound nerve stimulators electronic purposes medical electrical namely transcutaneous stimulation instruments